Gelteq to Present at Investor Summit Virtual on December 9, 2025
Stocks in this Quantisnow insightHealth Care
Historical context for GELS
Across the 3 sessions after earlier GELS headlines, the stock closed higher 2 times and lower 1 times, with a median move of 5.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GELS | SPY |
|---|---|---|---|
| Nov 24, 2025 | Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform | +20.4% | +1.5% |
| Nov 17, 2025 | Healthy Extracts Reports Record Q3 2025, with Revenue up 23% | -5.8% | -0.9% |
| Nov 11, 2025 | Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025 | +5.9% | +0.2% |
Quantisnow market dataNASDAQ
GELS
Gelteq Limited
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2024
Get push alerts for GELS
Full GELS profile on Quantisnow Follow GELS and get a push notification the moment its next story breaks.